SAP files annual report for 2025 with SEC and releases integrated report

Dr. h. c. mult. Pekka Ala-Pietilae Chairman of the Supervisory Board SAP SE SAP SE
Dr. h. c. mult. Pekka Ala-Pietilae Chairman of the Supervisory Board SAP SE - SAP SE
0Comments

SAP SE has announced the filing of its Annual Report on Form 20-F for the year ending December 31, 2025, with the U.S. Securities and Exchange Commission (SEC). The report is available online at https://www.sap.com/docs/download/investors/2025/sap-2025-annual-report-form-20f.pdf. In addition, SAP released its Integrated Report 2025, which can be accessed at https://www.sapintegratedreport.com.

PDF versions of both reports are available on SAP’s Investor Relations website at https://www.sap.com/investor. Stakeholders can request a hard copy of the audited consolidated financial statements free of charge by emailing [email protected] or calling +49 (6227) 7-67336.

SAP is recognized as a global leader in enterprise applications and business AI. The company has provided solutions for organizations worldwide for over five decades, supporting operations across finance, procurement, HR, supply chain, and customer experience. More information about SAP can be found at www.sap.com.

Further details for investors are available through Alexandra Steiger at +49 (6227) 7-767336 or via email at [email protected]. Press inquiries can be directed to Marcus Winkler at +46 (6227) 7-67497 or [email protected], and Daniel Reinhardt at +49 (6227) 7-40201 or [email protected].

Customers interested in SAP products may contact the Global Customer Center at +49 180 534-34-24 or, in the United States, call +1 (800) 872-1SAP (+1-800-872-1727).

The company notes that its filings may contain forward-looking statements based on current expectations and assumptions subject to risks and uncertainties. Further information about these risks is included in the risk factors section of SAP’s 2025 Annual Report on Form 20-F.

High-resolution press photos and broadcast-standard stock footage are available for download from www.sap.com/photos.

All trademarks mentioned are property of SAP SE in Germany and other countries. Additional trademark information is available at https://www.sap.com/copyright.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.